.jpg?format=auto&onerror=redirect&width=300)
United States
A pair of new drugs offer something that most Americans desperately want: a way to lose weight.
Madrigal Pharmaceuticals' resmetirom is a leading treatment candidate for the advanced form of fatty liver disease.
The National School Lunch Program has succeeded in reducing student hunger. Now it needs to address the metabolic dysfunction it helped promote.
The USDA-produced graphic was in every classroom in the 90s; here's why it finally went away, and the challenges that remain.
Last May, a graduate student named Jack Lawrence sat down in his apartment and began combing through a medical study about ivermectin for his coursework at the University of London. The study, conducted by researchers at Benha University in Egypt and published in November 2020, had produced stunning results.
The Biden administration's decision to make COVID-19 booster shots available to millions of vaccinated adults may speak more to the economics of the pandemic than the science. For the last two months, scientists and federal officials have debated whether COVID-19 boosters are needed - right now, or at all - and, if so, who should get them.
Millions of Americans are getting their COVID-19 shots every day, but the U.S. is still going to need better treatments that can nip mild or moderate cases of COVID-19 before they become serious. There are a number of reasons that people could still get sick after they are vaccinated.
Cherie Jennings picked up and moved her family across the country to Great Falls, Montana, this summer. She had been living in Franklin, N.
By the end of 2017, Matt Crecelius decided it was time. He wanted to live somewhere cheaper, with a slower pace.